Clinical Trial Update: Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies

View source ↗

Summary

The study completed an ex-vivo performance evaluation of the Histolog Scanner for detecting breast carcinoma on fresh breast core biopsies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Brust-Zentrum AG | Conditions: Breast Cancer | Status: COMPLETED